Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.5600
-0.0050 (-0.88%)
Aug 7, 2026, 4:13 PM AEST
Aroa Biosurgery Cash Flow Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 4.68 | -3.81 | -10.63 | -0.4 | -8.39 |
Depreciation & Amortization | 4.51 | 4.27 | 4.3 | 3.83 | 3.13 |
Other Amortization | 0.75 | 0.67 | 0.1 | - | 0.05 |
Loss (Gain) From Sale of Assets | - | 0.01 | - | 0.01 | 0 |
Asset Writedown & Restructuring Costs | 0.28 | - | - | - | - |
Stock-Based Compensation | 1.67 | 2.16 | 3.18 | 2.58 | 2.97 |
Other Operating Activities | -0.39 | 1.75 | 2.39 | 0.11 | 1.35 |
Change in Accounts Receivable | -5.83 | -2.89 | 0.9 | -2.24 | -8.35 |
Change in Inventory | 2.25 | -0.17 | -3.27 | -2.75 | -0.32 |
Change in Accounts Payable | 5.02 | -0.4 | 0.11 | 1.84 | 1.32 |
Change in Unearned Revenue | 1.29 | - | - | - | - |
Change in Income Taxes | 0.12 | -0 | -0.03 | -0.39 | 0.09 |
Change in Other Net Operating Assets | -3.79 | -4.15 | -4.42 | -6.39 | -3.38 |
Operating Cash Flow | 10.55 | -2.57 | -7.38 | -3.77 | -11.52 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -1.11 | -2.31 | -3.52 | -6.03 | -4.46 |
Sale (Purchase) of Intangibles | -2.62 | -1.39 | -3.46 | -1.58 | -0.42 |
Investment in Securities | 8.01 | 4 | 17.13 | 14.87 | -30 |
Investing Cash Flow | 4.27 | 0.3 | 10.15 | 7.26 | -34.87 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Repaid | -1.35 | -1.01 | -0.74 | -0.65 | -10.09 |
Net Debt Issued (Repaid) | -1.35 | -1.01 | -0.74 | -0.65 | -10.09 |
Issuance of Common Stock | 0.08 | 0.01 | 0.11 | 0.17 | 50.32 |
Other Financing Activities | -0.47 | -0.48 | -0.41 | -0.03 | -2.6 |
Financing Cash Flow | -1.74 | -1.47 | -1.03 | -0.5 | 37.63 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Foreign Exchange Rate Adjustments | -0.01 | 0.21 | 0.24 | 0.4 | -0.46 |
Net Cash Flow | 13.07 | -3.53 | 1.98 | 3.38 | -9.22 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 9.44 | -4.88 | -10.9 | -9.8 | -15.98 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | 9.09% | -5.76% | -15.78% | -15.47% | -40.27% |
Free Cash Flow Per Share | 0.03 | -0.01 | -0.03 | -0.03 | -0.05 |
Levered Free Cash Flow | 6.57 | -3.96 | -11.84 | -11.88 | -13.56 |
Unlevered Free Cash Flow | 6.87 | -3.67 | -11.53 | -11.64 | -12.84 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 0.47 | 0.48 | 0.5 | 0.38 | 1.73 |
Cash Income Tax Paid | 0.39 | 0.56 | 0.27 | 0.57 | 0.02 |
Change in Working Capital | -0.94 | -7.61 | -6.71 | -9.91 | -10.64 |